Prenatal sonographic diagnosis of premature constriction of the fetal ductus arteriosus after maternal self-medication with benzydamine hydrochloride: report of 3 cases and review of the literature

J Ultrasound Med. 2015 Mar;34(3):531-5. doi: 10.7863/ultra.34.3.531.

Abstract

We report 3 cases of prenatal diagnosis of premature constriction of the ductus arteriosus after maternal benzydamine hydrochloride therapy (3-mg lozenges) in third-trimester pregnancies. In each case, fetal echocardiography revealed a dilated, hypocontractile right ventricle with severe tricuspid regurgitation and constriction of the ductus arteriosus. Although the effect of indomethacin and other nonsteroidal anti-inflammatory drugs on prenatal ductal constriction is well known, readily available over-the-counter nonsteroidal anti-inflammatory drugs such as benzydamine can have an equally deleterious effect and are best avoided in the third trimester of pregnancy.

Keywords: benzydamine hydrochloride; ductus arteriosus constriction; fetal echocardiography; obstetric ultrasound; prenatal diagnosis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / adverse effects
  • Benzydamine / adverse effects*
  • Constriction, Pathologic / chemically induced
  • Constriction, Pathologic / diagnostic imaging
  • Ductus Arteriosus / diagnostic imaging*
  • Ductus Arteriosus / drug effects*
  • Female
  • Heart Diseases / chemically induced*
  • Heart Diseases / diagnostic imaging*
  • Heart Diseases / embryology
  • Humans
  • Pregnancy
  • Self Medication / adverse effects
  • Ultrasonography, Prenatal / methods*

Substances

  • Anti-Inflammatory Agents
  • Benzydamine